EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Extracorporeal shockwave therapy improves post-breast reconstruction fibrosis: A randomized controlled blinded clinical trial

Antoinette T Nguyen, Jeewon Chon, Rena A Li, Bradley A Melnick, Anmar Abu-Romman, Rahim Laiwalla, Tarifa H Adam, Robert D Galiano

Journal of Plastic, Reconstructive & Aesthetic Surgery · 2025

DOI: 10.1016/j.bjps.2025.08.045 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Plastic, Reconstructive & Aesthetic Surgery, 2025. Verfasst von Antoinette T Nguyen und 7 weiteren Autor:innen. Beteiligte Einrichtung: University of Rochester School of Medicine, Rochester, NY, USA. Hauptthemen laut MEDLINE: Extracorporeal Shockwave Therapy, Mammaplasty, Breast, Postoperative Complications. Die Arbeit nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Fibrosis following breast reconstruction is a debilitating syndrome characterized by (1) restricted shoulder and upper extremity mobility, (2) chronic pain and discomfort, (3) poor tissue pliability, and (4) suboptimal aesthetic outcomes. This condition significantly impairs the quality of life and functional recovery. Currently, no therapeutics directly target fibrotic remodeling. Extracorporeal shockwave therapy (ESWT) uses targeted acoustic pulses to stimulate cellular regeneration, collagen remodeling, and tissue softening, and may offer a novel non-invasive intervention. METHODS: A single-blinded randomized controlled clinical trial was conducted in 40 adult women with clinically diagnosed postoperative fibrosis following breast reconstruction. Participants were randomized to receive either ESWT or sham treatment, delivered in eight biweekly sessions over four weeks, with follow-up at three months. The primary outcome was patient-reported breast softness. Secondary outcomes included pain, fibrosis size, shoulder mobility, observer assessments, and ultrasound-based tissue quality. RESULTS: Compared to the placebo group, the ESWT group demonstrated significantly greater improvements in breast softness (mean change: 4.92 ± 1.86 vs. 0.9 ± 1.48; p = 0.00003), pain (-2.00 ± 2.28 vs. +0.43 ± 2.16; p = 0.0052), and fibrosis size (3.88 ± 1.82 vs. 0.86 ± 1.59; p = 0.0015). Observer-rated outcomes also favored the treatment, including breast firmness (-2.12 ± 1.55 vs. -0.14 ± 1.77; p = 0.0013) and overall opinion (-2.04 ± 1.78 vs. -0.43 ± 1.74; p = 0.0003). Ultrasound scores improved across all metrics, including fibrosis depth (1.08 ± 0.74 vs. 0.57 ± 0.51; p = 1.57 × 10⁻⁵) and boundary definition (1.23 ± 0.65 vs. 0.29 ± 0.47; p = 5.30 × 10⁻⁵). CONCLUSION: ESWT significantly improved pain, softness, lesion size, and sonographic fibrosis features in patients with post-reconstruction fibrosis, demonstrating strong and sustained therapeutic benefit. CLINICAL TRIAL REGISTRATION: NCT06919042.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracorporeal Shockwave TherapyMammaplastyBreastPostoperative ComplicationsHumansFemaleFibrosisMiddle AgedSingle-Blind MethodAdultTreatment OutcomeQuality of LifeBreast Neoplasms

Stichwörter der Autor:innen

Breast reconstructionExtracorporeal shockwave therapy (ESWT)FibrosisOutcomesQuality of life

Autor:innen und Institutionen

  • University of Rochester School of Medicine, Rochester, NY, USA.
  • Loyola Stritch School of Medicine, Maywood, IL, USA.
  • Northwestern University Feinberg School of Medicine, Department of Surgery, Division of Plastic and Reconstructive Surgery, Chicago, IL, USA.
  • West Virginia School of Osteopathic Medicine, Lewisburg, WV, USA.
  • Northwestern University Feinberg School of Medicine, Department of Surgery, Division of Plastic and Reconstructive Surgery, Chicago, IL, USA. Electronic address: Robert.Galiano@nm.org.

Zitieren

APA

Nguyen, A. T., Chon, J., Li, R. A., Melnick, B. A., Abu-Romman, A., Laiwalla, R., Adam, T. H., & Galiano, R. D. (2025). Extracorporeal shockwave therapy improves post-breast reconstruction fibrosis: A randomized controlled blinded clinical trial. Journal of Plastic, Reconstructive & Aesthetic Surgery. https://doi.org/10.1016/j.bjps.2025.08.045

Vancouver

Nguyen AT, Chon J, Li RA, Melnick BA, Abu-Romman A, Laiwalla R, et al. Extracorporeal shockwave therapy improves post-breast reconstruction fibrosis: A randomized controlled blinded clinical trial. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2025. doi:10.1016/j.bjps.2025.08.045

BibTeX
@article{Nguyen2025,
  author = {Nguyen, Antoinette T and Chon, Jeewon and Li, Rena A and Melnick, Bradley A and Abu-Romman, Anmar and Laiwalla, Rahim and Adam, Tarifa H and Galiano, Robert D},
  title = {Extracorporeal shockwave therapy improves post-breast reconstruction fibrosis: A randomized controlled blinded clinical trial},
  journal = {Journal of Plastic, Reconstructive & Aesthetic Surgery},
  year = {2025},
  doi = {10.1016/j.bjps.2025.08.045}
}
Kostenlos starten →